Gracefix syrup

Dexa Medica

Ingredients in every 5 ml

Cefixime 100 mg

Each package contains

1 bottle of 60 ml

Other details

Dosage form:Syrup
Flavour Original

W.H.O. classification

ATC Level 1 J - Antiinfectives for systemic use
ATC Level 2 J01 - Antibacterials for Systemic Use
ATC Level 3 J01D - Other Beta-Lactam Antibacterials in ATC

Warnings

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

NOT RECOMMENDEDThis item should not be used while operating heavy machinery.

Available in

The Philippines

Dosage information

18 YEARS OLD AND ABOVE
Starcef capsule: 50-100 mg twice a day.
For severe infections, dosage may be increased up to 200 mg, given twice a day.

0 TO 18 YEARS OLD
Starcef capsule:
Children weighing ≥30 kg: 50-100 mg twice a day.
For severe infections, dosage may be increased up to 200 mg, given twice a day.

Starcef dry syrup: 1.5-3 mg (0.075-0.15 ml of Starcef dry syrup) per kg body weight, twice a day.
For severe infections, dosage may be increased up to 6 mg (0.3 ml of Starcef dry syrup) per kg body weight, twice a day.

Safety and efficacy of cefixime administration in children <6 months has not been established (including newborns and premature). PEDIATRICS WITH OTITIS MEDIA
It is recommended to treat with Starcef dry syrup.

PATIENTS WITH IMPAIRED RENAL FUNCTION
Patients with impaired renal function need a dosage adjustment depending on the degree of renal impairment. Recommended dosage: 75% of the standard dosage (i.e. 300 mg a day) if creatinine clearance is between 21 and 60 ml/minute or for patients on renal hemodialysis and 50% of the standard dosage (i.e. 200 mg a day) if creatinine clearance is <20 ml/minute or for patients on continuous ambulatory dialysis.

Indication

Treatment of infections caused by susceptible microorganisms, i.e.:
a. Urinary infections without complication caused by Escherichia coli and Proteus mirabilis.

b. Otitis media caused by Haemophilus influenzae (ß-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are ß-lactamase positive) and Streptococcus pyogenes.

c. Pharyngitis and tonsillitis caused by Streptococcus pyogenes.

d. Acute bronchitis and acute exacerbation of chronic bronchitis, caused by Streptococcus pneumoniae and Haemophilus influenzae (ß-lactamase positive and negative strains).